Drug
Bezafibrate clinical trials
- studies test it
- 17
- open now
- 2
- in phase 3
- 8
- first study started
- 2006
Keep track of what changes. Save the Bezafibrate studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
17 studies that test it; most in 2016 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 8
- Phase 3
- 8
- Phase 4
- 1
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 14
Assistance Publique - Hôpitaux de Paris (3) · Intercept Pharmaceuticals (2) · Instituto Mexicano del Seguro Social (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2) · Massachusetts General Hospital (1) · Hôpital Necker-Enfants Malades (1) · University of Guadalajara (1) · Newcastle-upon-Tyne Hospitals NHS Trust (1)
Often tested with
Tested in the same studies.
Obeticholic acid (2) · Berberine (1) · Diflunisal (1) · Valproic Acid (1) · Medroxyprogesterone (1) · Danazol (1)
Studies
Open first, then newest update. How each study uses Bezafibrate is read from its arms, and is right about nine times in ten.
Testing it · 17
- Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Biliary Cholangitis and Non-optimal Biochemical Response to Ursodeoxycholic Acid TherapyRecruitingPhase 3Assistance Publique - Hôpitaux de ParisNCT06443606Written as Bezafibrate 400 mg in addition to UDCA therapy
- Repurposed Drugs to Improve Haematological Responses in Myelodysplastic SyndromesRecruitingPhase 2Prof. Janet DunnNCT04997811Written as Sodium Valproate, Bezafibrate, Medroxyprogesterone
- BezafibrateTreatment for Bipolar Depression: A Proof of Concept StudyCompletedPhase 2Massachusetts General HospitalNCT02481245Written as Bezafibrate
- Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBCCompletedPhase 2Intercept PharmaceuticalsNCT05239468Written as Bezafibrate 100 mg
- Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBCTerminatedPhase 2Intercept PharmaceuticalsNCT04594694Written as Bezafibrate 200 MG
- Trial of Befizal® 200 mg for the Treatment of Leber Hereditary Optic NeuropathyCompletedPhase 2/3Hôpital Necker-Enfants MaladesNCT04561466Written as Béfizal
- Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary CirrhosisCompletedPhase 3Assistance Publique - Hôpitaux de ParisNCT01654731Written as Bezafibrate
- Bezafibrate Plus Berberine in Mixed DyslipidemiaCompletedPhase 3University of GuadalajaraNCT02548832Written as Bezafibrate
- A Study to Assess Efficacy and Safety of Bezafibrate in Patients With Primary Biliary CholangitisStatus unknownPhase 3Instituto Mexicano del Seguro SocialNCT04751188Written as Bezafibrate 200 MG Oral Tablet
- Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-respondersStatus unknownPhase 3Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranNCT02937012Written as Bezafibrate
- A Study of Bezafibrate in Mitochondrial MyopathyCompletedPhase 2Newcastle-upon-Tyne Hospitals NHS TrustNCT02398201Written as Bezafibrate
- The Effect of Bezafibrate on Cholestatic ItchStatus unknownPhase 3Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT02701166Written as Bezafibrate
- Bezafibrate for Hyperfibrinogenemia in Acute Myocardial InfarctionCompletedPhase 4Instituto Mexicano del Seguro SocialNCT02291796Written as Bezafibrate
- Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation DefectsCompletedPhase 2Rigshospitalet, DenmarkNCT00983788Written as Bezafibrate
- The Effect of Bezafibrate on the Level of Very Long Chain Fatty Acids (VLCFA) in X-linked Adrenoleukodystrophy (X-ALD)CompletedNot applicableAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT01165060Written as Bezafibrate
- Study of CRx-401 on Glucose Levels in Subjects With Type II DiabetesCompletedPhase 2ZalicusNCT00506298Written as bezafibrate + diflunisal
- Bezafibrate Trial in CPT2 DeficiencyStatus unknownPhase 3Assistance Publique - Hôpitaux de ParisNCT00336167Written as bezafibrate (drug)
Given in every arm · 1 — Bezafibrate is usual care beside what is tested
As the comparator · 1 — what is tested is compared with Bezafibrate
Codes
What other systems call Bezafibrate · ClinicalTrials.gg INT007071
- MeSH (NLM) D001629BezafibrateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) Y9449Q51XHBEZAFIBRATEConfirmed FDA, NLM, Wikidata
- RxNorm 1525Confirmed FDA, Wikidata
- Wikidata Q577387bezafibrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C87449BezafibrateOne source FDA
- DrugBank DB01393One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D001629 | Bezafibrate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | Y9449Q51XH | BEZAFIBRATE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1525 | — | Confirmed FDA, Wikidata |
| Wikidata | Q577387 | bezafibrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C87449 | Bezafibrate | One source FDA |
| DrugBank | DB01393 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.